ALL >> Business >> View Article
Actinic Keratosis Market To Reach Worth Usd 8.91 Bn By 2022
The purpose of the report is to illustrate the state of the market of Actinic Keratosis, to present actual information about the volumes of production, exports, imports, consumption and the state of the market, the changes that took place in 2017, and also, to build a forecast for the growth of the industry in the medium term until 2026.
Browse here for full report: https://www.credenceresearch.com/report/actinic-keratosis-market
Actinic keratosis (AK) is characterized by skin papules, macules or plaques resulting from prolonged exposure to harmful UV exposure and can result in squamous cell carcinoma. Risk of developing actinic keratosis increases with advancing age and is particularly higher in men as against women. About 5-20% of patients with actinic keratosis lesions develop malignant and potentially fatal squamous cell carcinomas.
Among the various treatment methods available, destructive therapies such as liquid nitrogen cryotherapy and surgical therapy constitute the gold standard for AK treatment. In 2015, cryotherapy was the most commonly sought treatment by clinicians. However, better clinical results of photodynamic therapy and growing preference for treatments based on drug-device combination have urged both caregivers and patients to opt for novel treatment methods that offer both advanced efficacy, aesthetic benefits and reduced risk of future malignancies. Topical treatment is a prolonged treatment and comparatively more effective than other treatments but patient compliance is the key issue that hinders the growth of this segment. Photodynamic therapy is the fastest growing treatment throughout the forecast period due to rising demand for non-invasive surgeries, and less treatment sessions are the key factors expected to assist this market
North America is the largest market for actinic keratosis treatment due to growing prevalence of AK, better public awareness about occurrence of AK and associated risk of squamous cell carcinoma. According to American Academy of Dermatology (AAD), approximately 60% of the Americans aged 40 year or above, Actinic Keratosis is predisposed to develop having at least 1 AK lesion. Actinic keratosis is precursors of squamous cell cancer. U.S. held the largest share in the actinic keratosis market in 2015 owing to current prevalence of actinic keratosis in the region.Asia Pacific is the fastest growing market for AK treatments. Australia has the highest prevalence of actinic keratosis ranging between 40% to 60% in adult population. Growing awareness in the region and rapid development in healthcare infrastructure and healthcare expenditure are the key growth factors in Asia Pacific actinic keratosis market.
This market is majorly driven by wide presence of generic drugs and is moderately competitive. Photodynamic therapy market has developed a niche with methyl aminolevulinate and aminolevulinic acid drugs. Galderma and DUSA pharmaceuticals are the chief players in this space. Some of the major players in the global actinic keratosis market are Tolmar Pharmaceuticals, Inc, DUSA Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Aqua Pharmaceuticals, LLC, Galderma SA, Perrigo Company plc, LEO Laboratories, Apotex and others.
Why was the report written?
This report is the result of an extensive survey drawn from Credence Research’s exclusive panel of leading global market industry executives; it provides data and analysis on buyer investment, acquisition, and developments within the global market research. It includes key topics such as global Actinic Keratosis buyer expenditure and procurement behaviors and strategies and recognizes the threats and possibilities within the industry, economic outlook trends, and business confidence within global industry executives. Most secondary research reports are based on general industry drivers and do not understand the industry executives’ attitude and changing behaviors, creating a gap in presenting the business outlook of the industry; in an effort to bridge this gap, Credence Research created this primary research-based report by gathering the opinions of multiple stakeholders in the value chain of the global industry.
What is the current market landscape and what is changing?
Executives from the global industry anticipate an increase in levels of consolidation, with 55% of respondents projecting an increase in merger and acquisition (M&A) activities in 2017.
The report on the market of Actinic Keratosis contains:
Analysis and forecast of Actinic Keratosis market dynamics;
Analysis of domestic production, market shares of the main market players;
Analysis of exports and imports;
Analysis of factors, leading the development of the Actinic Keratosis market;
Assessment and forecast of Actinic Keratosis market development;
Financial and business profiles of the leading companies in the Actinic Keratosis industry.
- Up to date working Actinic Keratosis data by major regions in the world, the forecast of planned capacity additions by 2026
- The annual breakdown of capital expenditure spending on proposed Actinic Keratosis for the period 2018 to 2026
- Planned Actinic Keratosis additions and capital expenditure spending by key countries and companies across the world
- Planned capital expenditure spending on new Actinic Keratosis projects by region, key countries, and companies
- Details of major planned Actinic Keratosis projects in the world up to 2026
Also you can request us for sample in pdf with more details and graph: https://www.credenceresearch.com/sample-request/58011
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Company Name: Credence Research, Inc
Contact Person: Chris Smith, Global Sales Manager
Email: Send Email
Address:105 N 1st ST #429, SAN JOSE, CA 95103 US
City: SAN JOSE
Country: United States
Business Articles1. What Is The Need To Digitize The Processes At Manufacturing Plants?
Author: radhika jain
2. Scoping Out The Best Franchise Opportunities In Canada – Here Is What You Need To Know
Author: Canadian Franchising Magazine
3. Printing Techniques Best Options To Get The Best Business Cards
Author: Vikram Kumar
4. Types Of Water Pumps And Their Use
Author: K V Gopalkrishna
5. Why Is Septic Tank Spring Maintenance Beneficial?
Author: Solo IT
6. Yacht Charter Companies Fort Lauderdale
7. How To Hire A Hacker
8. Ceramic Matrix Composites Market: Regional Analysis And Business Opportunity And Global Demand By Fo
Author: Market Research Future
9. The Benefits Of Blue Sapphire - Power & Significance Of Color
Author: Soli Sethi
10. Gartner Shows It’s A Long, Long Road For Blockchain Technology
Author: Nivya Desai
11. Various Work From Home Options
Author: The Yellow Coin Communication
12. Historia Clinica Web
13. Apollo Butterfly Valves
14. Translation Services In Visa Processing
Author: The Yellow Coin Communication
15. Seven Benefits Of Pflow Model M Vertical Lift System Suitable To Transport Large And Heavy Loads
Author: Overhead Door of Eastern New Jersey Commercial